Skip to main content
. 2017 Jun 30;14(1):107–114. doi: 10.5114/aoms.2017.68696

Figure 1.

Figure 1

Concentrations of IL-1β in serum (A), stool (B) and IL-1ra in serum (C) in active ulcerative colitis (UC) patients who had experienced complications during the 5-year follow-up period compared to the group without any complications. Data are expressed as median values and ranges. Differences statistically significant with p-value < 0.05 and < 0.01, respectively